{"id":10951,"date":"2025-05-14T16:00:01","date_gmt":"2025-05-14T16:00:01","guid":{"rendered":"https:\/\/sescs.es\/?p=10951"},"modified":"2025-05-14T16:00:01","modified_gmt":"2025-05-14T16:00:01","slug":"qualitative-evidence-synthesis-csii","status":"publish","type":"post","link":"https:\/\/sescs.es\/en\/qualitative-evidence-synthesis-csii\/","title":{"rendered":"SESCS PUBLICATION: A qualitative evidence synthesis of continuous subcutaneous insulin infusion: acceptability, implementation, equity"},"content":{"rendered":"
Ana Toledo-Ch\u00e1varri, Janet Delgado, Mar\u00eda Padilla, Beatriz Rodr\u00edguez-Mart\u00edn<\/p>\n
ABSTRACT<\/strong><\/p>\n
This work provides a synthesis of the perceptions of people with type 1 diabetes mellitus (T1DM) and healthcare professionals regarding the acceptability, implementation, and equity of continuous subcutaneous insulin infusion (CSII). A qualitative evidence synthesis was carried out. Three online databases (Medline, Embase, and Web of Science) were searched. Qualitative articles available in Spanish or English were included. A descriptive thematic synthesis was conducted according to PRISMA and ENTREQ guidelines.<\/p>\n
Thirty-two references met the inclusion criteria of the study and were included from an initial 345 identified references. Seven main themes were identified: \n(a) acceptability, \n(b) adaptation to the insulin pump, \n(c) facilitators for the adequate use of the insulin pump, \n(d) variability of acceptability, \n(e) barriers to the use of the insulin pump, \n(f) feasibility and implementation considerations, and \n(g) equity.<\/p>\n
CSII is well accepted by most people with T1DM, with some exceptions. It can relieve the burden of disease management, increase autonomy and flexibility, and improve family relationships. There were multiple perceived barriers to its continued use. Future studies should continue to analyze inequalities in access to and use of CSII.<\/p>\n